Volex has experienced significant growth on the AIM, with its market capitalization increasing from £30m to £500m over eight years, during which it also raised capital. However, concerns are being raised about the status of London's AIM and the broader UK small cap market. Critics argue that London's position as a global financial center is under threat, necessitating reform. This sentiment is echoed by the recent trend of companies, including e_therapeutics ($ETX), CX4 Discovery, and RedxPharma ($REDX), considering delisting from AIM in favor of other markets like the NYSE. Additionally, the UK small cap market is being gutted, part of a larger pattern of tech company exoduses from markets such as Australia's, highlighting a global shift in where companies choose to list.
Australian stock market faces tech company exodus https://t.co/mMR4pHtamk
Exodus from AIM leaves chorus of questions in its wake (behind paywall). Some companies looking to delist @e_therapeutics (to list on NYSE), CX4 Discovery and @RedxPharma. $ETX $REDX https://t.co/ishKmg9oLj
UK small cap market is being gutted… https://t.co/BBWyJsytSi
AIM has been a good home for @Volex-we have grown from a £30m to a £500m mkt cap in 8 years and raised capital along the way.A London listing is still a great platform for ambitious companies but London's status as a global bourse is clearly under threat! https://t.co/2oHejn4gPf
AIM has been a good home for @Volex-we have grown from a £30m to a £500m mkt cap in 8 years and raised capital along the way. A London listing is still a great platform for ambitious companies but London's status a global bourse is clearly under threat! https://t.co/pyeBX6oH3N
AIM has been a good home for @Volex - we’ve grown from a market cap of £30m to £500m in 8 years, raising capital along the way. A London listing is still a great platform for ambitious companies but it’s status as a global bourse is clearly under threat - reform is badly needed!…